Paul Tudor Jones’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,100
Closed -$488K 3773
2026
Q1
$488K Sell
6,100
-1,500
-20% -$124K ﹤0.01% 2836
2025
Q4
$648K Sell
7,600
-13,300
-64% -$1.09M ﹤0.01% 2562
2025
Q3
$1.63M Buy
20,900
+3,400
+19% +$266K ﹤0.01% 1941
2025
Q2
$1.37M Buy
17,500
+4,800
+38% +$358K ﹤0.01% 1931
2025
Q1
$920K Buy
12,700
+9,900
+354% +$709K ﹤0.01% 1866
2024
Q4
$207K Sell
2,800
-4,800
-63% -$336K ﹤0.01% 2826
2024
Q3
$502K Buy
7,600
+3,800
+100% +$276K ﹤0.01% 2033
2024
Q2
$351K Buy
+3,800
New +$337K ﹤0.01% 1957
2024
Q1
Sell
-3,300
Closed -$252K 2371
2023
Q4
$252K Sell
3,300
-6,800
-67% -$473K ﹤0.01% 2107
2023
Q3
$700K Buy
10,100
+3,800
+60% +$305K 0.01% 1506
2023
Q2
$594K Buy
+6,300
New +$548K 0.01% 1615
2023
Q1
Sell
-25,900
Closed -$1.93M 2574
2022
Q4
$1.93M Buy
25,900
+18,700
+260% +$1.44M 0.04% 652
2022
Q3
$595K Buy
7,200
+900
+14% +$86.6K 0.01% 1276
2022
Q2
$600K Buy
6,300
+4,500
+250% +$466K 0.02% 1179
2022
Q1
$213K Sell
1,800
-1,200
-40% -$135K 0.01% 1731
2021
Q4
$390K Buy
+3,000
New +$350K 0.01% 1652

Other funds holding EW

Paul Tudor Jones's EW Position: Q2 2025 in Review

Paul Tudor Jones sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 115,014 shares — an estimated $8.58M sold.

Paul Tudor Jones first reported a position in EW in Q3 2013 and held it in 30 quarters. The position peaked at $19.6M in Q1 2017. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Paul Tudor Jones reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 115,014 Edwards Lifesciences shares in Q2 2025, an estimated $8.58M.
  • Paul Tudor Jones first reported a position in Edwards Lifesciences in Q3 2013 and held it in 30 quarters.
  • Paul Tudor Jones's Edwards Lifesciences position peaked at $19.6M in Q1 2017.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.